Drug Shortage Report for VIADERM KC ONT
Report ID | 178102 |
Drug Identification Number | 00717029 |
Brand name | VIADERM KC ONT |
Common or Proper name | VIADERM |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | NYSTATIN GRAMICIDIN NEOMYCIN TRIAMCINOLONE ACETONIDE |
Strength(s) | 100000UNIT 0.25MG 2.5MG 1MG |
Dosage form(s) | OINTMENT |
Route of administration | TOPICAL TOPICAL |
Packaging size | 30 |
ATC code | D07CB |
ATC description | CORTICOSTEROIDS, COMB WITH ANTIBIOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-11-28 |
Estimated end date | 2023-01-04 |
Actual end date | 2022-12-30 |
Shortage status | Resolved |
Updated date | 2023-01-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-12-12 | English | Compare |
v2 | 2022-12-12 | French | Compare |
v3 | 2023-01-10 | English | Compare |
v4 | 2023-01-10 | French | Compare |
Showing 1 to 4 of 4